Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Pittenger

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Molecular Psychiatry|May 27, 2009
Meta-analysis of the dose-response relationship of SSRI in obsessive-compulsive disorderM H Bloch, J McGuire, A Landeros-Weisenberger, et al.
Antibiotics & Chemotherapy (Northfield, Ill.)|February 19, 2014
Laboratory studies on ilotycinH M POWELL, W S BONIECE, R C PITTENGER, et al.
Chronic Stress (Thousand Oaks, Calif.)|March 13, 2018
The role of stress in the pathogenesis and maintenance of obsessive-compulsive disorderT G Adams, B Kelmendi, C A Brake, et al.
Translational Psychiatry|May 2, 2013
Orbitofrontal cortex neurofeedback produces lasting changes in contamination anxiety and resting-state connectivityD Scheinost, T Stoica, J Saksa, et al.
Neuron|October 18, 2001
Some forms of cAMP-mediated long-lasting potentiation are associated with release of BDNF and nuclear translocation of phospho-MAP kinaseS L Patterson, C Pittenger, A Morozov, et al.
Antibiotics & Chemotherapy (Northfield, Ill.)|February 19, 2014
Hygromycin. I. Preliminary studies on the production and biologic activity of a new antibioticR C PITTENGER, R N WOLFE, M M HOEHN, et al.
Molecular Psychiatry|June 11, 2014
Meta-analysis: hoarding symptoms associated with poor treatment outcome in obsessive-compulsive disorderM H Bloch, C A Bartley, L Zipperer, et al.
Annals of the New York Academy of Sciences|July 29, 1994
Recent insights on DNA repair. The mechanism of damaged nucleotide excision in eukaryotes and its relationship to other cellular processesA J Bardwell, L Bardwell, Z Wang, et al.
Translational Psychiatry|July 12, 2012
The tyrosine phosphatase STEP: implications in schizophrenia and the molecular mechanism underlying antipsychotic medicationsN C Carty, J Xu, P Kurup, et al.
Molecular Psychiatry|April 12, 2017
Ketamine-induced reduction in mGluR5 availability is associated with an antidepressant response: an [<sup>11</sup>C]ABP688 and PET imaging study in depressionI Esterlis, N DellaGioia, R H Pietrzak, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Molecular Psychiatry|May 27, 2009
Meta-analysis of the dose-response relationship of SSRI in obsessive-compulsive disorderM H Bloch, J McGuire, A Landeros-Weisenberger, et al.
Antibiotics & Chemotherapy (Northfield, Ill.)|February 19, 2014
Laboratory studies on ilotycinH M POWELL, W S BONIECE, R C PITTENGER, et al.
Chronic Stress (Thousand Oaks, Calif.)|March 13, 2018
The role of stress in the pathogenesis and maintenance of obsessive-compulsive disorderT G Adams, B Kelmendi, C A Brake, et al.
Translational Psychiatry|May 2, 2013
Orbitofrontal cortex neurofeedback produces lasting changes in contamination anxiety and resting-state connectivityD Scheinost, T Stoica, J Saksa, et al.
Neuron|October 18, 2001
Some forms of cAMP-mediated long-lasting potentiation are associated with release of BDNF and nuclear translocation of phospho-MAP kinaseS L Patterson, C Pittenger, A Morozov, et al.
Antibiotics & Chemotherapy (Northfield, Ill.)|February 19, 2014
Hygromycin. I. Preliminary studies on the production and biologic activity of a new antibioticR C PITTENGER, R N WOLFE, M M HOEHN, et al.
Molecular Psychiatry|June 11, 2014
Meta-analysis: hoarding symptoms associated with poor treatment outcome in obsessive-compulsive disorderM H Bloch, C A Bartley, L Zipperer, et al.
Annals of the New York Academy of Sciences|July 29, 1994
Recent insights on DNA repair. The mechanism of damaged nucleotide excision in eukaryotes and its relationship to other cellular processesA J Bardwell, L Bardwell, Z Wang, et al.
Translational Psychiatry|July 12, 2012
The tyrosine phosphatase STEP: implications in schizophrenia and the molecular mechanism underlying antipsychotic medicationsN C Carty, J Xu, P Kurup, et al.
Molecular Psychiatry|April 12, 2017
Ketamine-induced reduction in mGluR5 availability is associated with an antidepressant response: an [<sup>11</sup>C]ABP688 and PET imaging study in depressionI Esterlis, N DellaGioia, R H Pietrzak, et al.
Pageof 3